Risk of traffic accidents in patients with sleep-disordered breathing: reduction with nasal CPAP

Sleepiness whilst driving constitutes a road safety risk. Sleep-related breathing disorders are the most frequent medical cause of daytime sleepiness, and untreated patients with this condition have been shown to be at a higher risk of having accidents while driving. This study addressed the question of the extent to which treatment of sleep-disordered breathing by nasal continuous positive airway pressure (nCPAP) is related to changes in patient's accident risk. Seventy eight male patients requiring treatment of sleep-related breathing disorders with nCPAP were enrolled in the study. The protocol included a questionnaire dealing with alertness-related problems while driving, an 80 min vigilance test, and the Multiple Sleep Latency Test. These baseline evaluations were repeated after 1 year of treatment with nCPAP. Fifty nine patients completed the study. The accident rate was significantly decreased from 0.8 per 100,000 km (untreated) to 0.15 per 100,000 km with nCPAP treatment. Variables that were considered to be likely to increase accident risk (sleeping spells, fatigue, vigilance test reaction time, daytime sleep latency) also improved with treatment. We conclude that treatment of sleep-disordered breathing by nasal continuous positive airway pressure is related to reduction in patient motor vehicle accident rates, probably due to the reversal of excessive daytime sleepiness.

This article has been cited by other articles:

				E. Nena, V. Tsara, P. Steiropoulos, T. Constantinidis, Z. Katsarou, P. Christaki, and D. Bouros Sleep-Disordered Breathing and Quality of Life of Railway Drivers in Greece Chest, July 1, 2008; 134(1): 79 - 86. [Abstract] [Full Text] [PDF]

				M. H. Sanders, J. M. Montserrat, R. Farre, and R. J. Givelber Positive Pressure Therapy: A Perspective on Evidence-based Outcomes and Methods of Application Proceedings of the ATS, February 15, 2008; 5(2): 161 - 172. [Abstract] [Full Text] [PDF]

				J. Krieger Sleep apnoea and driving: how can this be dealt with? Eur. Respir. Rev., December 1, 2007; 16(106): 189 - 195. [Abstract] [Full Text] [PDF]

				N. T. Ayas, J. M. FitzGerald, J. A. Fleetham, D. P. White, M. Schulzer, C. F. Ryan, R. Ghaeli, G. W. Mercer, P. Cooper, M. C. Y. Tan, et al. Cost-effectiveness of Continuous Positive Airway Pressure Therapy for Moderate to Severe Obstructive Sleep Apnea/Hypopnea. Arch Intern Med, May 8, 2006; 166(9): 977 - 984. [Abstract] [Full Text] [PDF]

				M. Orth, H-W. Duchna, M. Leidag, W. Widdig, K. Rasche, T. T. Bauer, J. W. Walther, J. de Zeeuw, J-P. Malin, G. Schultze-Werninghaus, et al. Driving simulator and neuropsychological testing in OSAS before and under CPAP therapy Eur. Respir. J., November 1, 2005; 26(5): 898 - 903. [Abstract] [Full Text] [PDF]

				C F P George Sleep {middle dot} 5: Driving and automobile crashes in patients with obstructive sleep apnoea/hypopnoea syndrome Thorax, September 1, 2004; 59(9): 804 - 807. [Abstract] [Full Text] [PDF]

				A. S. M. Shamsuzzaman, B. J. Gersh, and V. K. Somers Mechanisms and Treatment of Obstructive Sleep Apnea--Reply JAMA, February 4, 2004; 291(5): 557 - 558. [Full Text] [PDF]

				P M Turkington, M Sircar, D Saralaya, and M W Elliott Time course of changes in driving simulator performance with and without treatment in patients with sleep apnoea hypopnoea syndrome Thorax, January 1, 2004; 59(1): 56 - 59. [Abstract] [Full Text] [PDF]

				J. Mar, J.R. Rueda, J. Duran-Cantolla, C. Schechter, and J. Chilcott The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea Eur. Respir. J., March 1, 2003; 21(3): 515 - 522. [Abstract] [Full Text] [PDF]

				W.T. McNicholas and J. Krieger on behalf of the Ta and Members of the Task Force: W.T. McNicholas , P. Le Public health and medicolegal implications of sleep apnoea Eur. Respir. J., December 1, 2002; 20(6): 1594 - 1609. [Full Text] [PDF]

				C. F. P. George, L. J. Findley, M. A. Hack, and R. D. McEvoy Across-Country Viewpoints on Sleepiness during Driving Am. J. Respir. Crit. Care Med., March 15, 2002; 165(6): 746 - 749. [Full Text] [PDF]

				S. Garrigue, P. Bordier, P. Jais, D. C. Shah, M. Hocini, C. Raherison, M. Tunon De Lara, M. Haissaguerre, and J. Clementy Benefit of Atrial Pacing in Sleep Apnea Syndrome N. Engl. J. Med., February 7, 2002; 346(6): 404 - 412. [Abstract] [Full Text] [PDF]

				C F P George Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP Thorax, July 1, 2001; 56(7): 508 - 512. [Abstract] [Full Text] [PDF]

				L. FINDLEY, C. SMITH, J. HOOPER, M. DINEEN, and P. M. SURATT Treatment with Nasal CPAP Decreases Automobile Accidents in Patients with Sleep Apnea Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 857 - 859. [Abstract] [Full Text] [PDF]

				M. Hack, R. J O Davies, R. Mullins, S. J. Choi, S. Ramdassingh-Dow, C. Jenkinson, and J. R Stradling Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnoea Thorax, March 1, 2000; 55(3): 224 - 231. [Abstract] [Full Text]

				M. Lertzman and S. Sharma Driving for safety on our roads Can. Med. Assoc. J., September 1, 1999; 161(6): 687 - 687. [Full Text] [PDF]

				F. BARBE, J. PERICAS, A. MUNOZ, L. FINDLEY, J. M. ANTO, A. G.N. AGUSTI, and M. de LLUC JOAN Automobile Accidents in Patients with Sleep Apnea Syndrome . An Epidemiological and Mechanistic Study Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 18 - 22. [Abstract] [Full Text] [PDF]

				D. Silverberg, A. Oksenberg, A. Iaina, and E. J. Roccella The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and Obstructive Sleep Apnea: Let Their Silence Not Be Matched by the Silence of the Ordinary Physician Arch Intern Med, June 8, 1998; 158(11): 1272 - 1273. [Full Text] [PDF]